Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
ICON Public Limited Company provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $5.5B | $7.7B | $8.1B | $8.2B | $8.3B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $391.5M | $378.5M | $795.2M | $904.7M | $1.0B | $442.8M |
| Net income | $332.3M | $153.2M | $505.3M | $554.2M | $739.1M | $229.3M |
| Diluted EPS | $6.15 | $2.25 | $6.13 | $6.70 | $8.90 | $2.90 |
| Operating cash flow | $568.0M | $829.1M | $563.3M | $1.2B | $1.3B | $1.0B |
| Free cash flow | $527.1M | $735.4M | $421.2M | $1.0B | $1.1B | $862.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 14.0% | 6.9% | 10.3% | 11.2% | 12.6% | 5.4% |
| Net margin | 11.9% | 2.8% | 6.5% | 6.9% | 9.0% | 2.8% |
| Line item | Q3 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0B | $2.0B | $2.1B | $2.0B | $2.0B | $2.1B | $2.1B | $2.0B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $157.0M | $302.6M | $330.4M | $227.0M | $230.9M | -$222.9M | $207.8M | $173.7M |
| Net income | $82.8M | $213.3M | $294.7M | $160.8M | $203.5M | -$284.2M | $149.2M | $104.8M |
| Diluted EPS | $0.99 | $2.56 | $3.57 | $1.99 | $2.56 | -$3.67 | $2.02 | $1.36 |
| Operating cash flow | $218.6M | $402.7M | $338.3M | $268.2M | $146.2M | $387.6M | $234.2M | $167.0M |
| Free cash flow | $182.3M | $359.3M | $277.0M | $239.3M | $113.9M | $333.9M | $174.8M | $136.2M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 7.7% | 14.8% | 16.0% | 11.3% | 11.3% | -10.7% | 9.8% | 8.5% |
| Net margin | 4.1% | 10.4% | 14.3% | 8.0% | 10.0% | -13.6% | 7.1% | 5.2% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.